A carregar...
Atomoxetine improves memory and other components of executive function in young-adult rats and aged rhesus monkeys
Atomoxetine is a norepinephrine reuptake inhibitor and FDA-approved treatment for attention deficit/hyperactivity disorder (ADHD) in children, adolescents, and adults. While there is some evidence that atomoxetine may improve additional domains of cognition beyond attention in both young adults and...
Na minha lista:
| Publicado no: | Neuropharmacology |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6839761/ https://ncbi.nlm.nih.gov/pubmed/31108108 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuropharm.2019.05.016 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|